Sage Journals: Discover world-class research

Abstract

French

The objectives of this article are to review the diagnosis and management of acute nonrenal reactions to iodinated contrast media. We will begin by discussing the types of contrast media and their correlative rates of reaction. The mechanism of contrast reactions, predisposing risk factors, and preventative measures will then be discussed. The remainder of the article will review the assessment of potential reactions, initial management, and treatment algorithms for specific reactions.

Keywords

Acute reactions Iodinated contrast

Get full access to this article

View all access options for this article.

References

Bush

W.H.

Jr. Krecke

K.N.

King

B.F.

Jr.

Radiology Life Support

1999

Arnold

London 1–57

Maddox

T.G.

Adverse reactions to contrast material: recognition, prevention, and treatment

Am Fam Physician 2002; 66:1229–1235.

Riemann

C.D.

Massey

C.V.

McCarron

D.L.

Ionic contrast agent-mediated endothelial injury causes increased platelet deposition to vascular surfaces

Am Heart J 1993; 125:71–78.

Eliasen

Horup

Jensen

A.R.

Thrombosis following phlebography with high-osmolar and low-osmolar contrast media

Eur J Radiol 1983; 3:97–98.

Thomsen

H.S.

Morcos

S.K.

Contrast Media Safety Committee of European Society of Urogenital Radiology

Management of acute adverse reactions to contrast media

Eur Radiol 2004; 14:476–481.

Thomsen

H.S.

Dorph

High-osmolar and low-osmolar contrast media: an update on frequency of adverse drug reactions

Acta Radiol 1993; 34:205–209.

Thomsen

H.S.

Bush

W.H.

Jr.

Adverse effects of contrast media: incidence, prevention, and management

Drug Saf 1998; 19:313–324.

Katayama

Yamaguchi

Kozuka

Adverse reactions to ionic and nonionic contrast media

Radiology 1990; 175:270–276.

Halvorsen

R.A.

Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging

Radiology 2008; 249:9–15.

10.

Bush

W.H.

Jr. Segal

A.J.

Recognition and treatment of acute contrast reactions

Appl Radiol 2009; 38:16–21.

11.

Lasser

E.C.

Chasing contrast molecules: a 45-year quixotic quest

Acad Radiol 2004; 11:1190–1196.

12.

Morcos

S.K.

Acute serious and fatal reactions to contrast media: our current understanding

Br J Radiol 2005; 78:686–693.

13.

Lasser

E.C.

Etiology of anaphylactoid responses: the promise of nonionics

Invest Radiol 20 suppl 1985 S79–S83.

14.

Lasser

E.C.

A coherent biochemical basis for increased reactivity to contrast material in allergic patients: a novel concept

AJR Am J Roentgenol 1987; 149:1281–1285.

15.

Lasser

E.C.

A general and personal perspective on contrast material research

Invest Radiol 23 suppl 1 1988 S71–S74.

16.

Namasivayam

Kalra

M.K.

Torres

W.E.

Adverse reactions to intravenous iodinated contrast media: an update

Curr Probl Diagn Radiol 2006; 35:164–167.

17.

Bush

W.H.

Jr. Swanson

D.P.

Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment

AJR Am J Roentgenol 1991; 157:1153–1161.

18.

Lang

D.M.

Alpern

M.B.

Visintainer

P.F.

Increased risk for anaphylactoid reaction from contrast media in patients on β-adrenergic blockers with asthma

Ann Intern Med 1991; 115:270–276.

19.

Lang

D.M.

Alpern

M.B.

Visintainer

P.F.

Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders

Arch Intern Med 1993; 153:2033–2040.

20.

Choyke

P.L.

Miller

D.L.

Lotze

M.T.

Delayed reactions to contrast media after interleukin-2 immunotherapy

Radiology 1992; 183:111–114.

21.

Celik

Hoppe

Lorenz

Randomized study comparing a non-ionic with an ionic contrast medium in patients with malignancies: first answer with a new diagnostic approach

Inflamm Res 48 suppl 1 1999 S47–S48.

22.

Lasser

E.C.

Berry

C.C.

Talner

L.B.

Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material

N Engl J Med 1987; 317:845–849.

23.

Greenberger

P.A.

Patterson

Radin

R.C.

Two pretreatment regimens for high-risk patients receiving radiographic contrast media

J Allergy Clin Immunol 1984; 74:540–543.

24.

Davies

Roberts

M.B.

Roylance

Acute reactions to urographic contrast media

Br Med J 1975; 2:434–437.

25.

Hunt

C.H.

Hartman

R.P.

Hesley

G.K.

Frequency and severity of adverse effects of iodinated and gadolinium contrast materials: retrospective review of 456,930 doses

AJR Am J Roentgenol 2009; 193:1124–1127.

26.

Shehadi

W.H.

Death following intravascular administration of contrast media

Acta Radiol Diagn 1985; 26:457–461.

27.

Thomsen

H.S.

Morcos

S.K.

ESUR guidelines on contrast media

Abdom Imaging 2006; 31:131–140.

28.

Field

J.M.

Advanced Cardiovascular Life Support Provider Manual

2006

American Heart Association

Dallas, TX

26–31.

29.

Celli

B.R.

MacNee

ATS/ERS Task Force

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Eur Respir J 2004; 23:932–946.

30.

Van Sonnenberg

Neff

C.C.

Pfister

R.C.

Life-threatening hypotensive reactions to contrast administration: comparison of pharmacologic and fluid therapy

Radiology 1987; 162:15–19.

31.

Jafri

S.Z.H.

Diokno

A.C.

Amendola

M.A.

Lower Genitourinary Radiology: Imaging and Intervention

1998

Springer-Verlag

New York, NY 547

32.

Callahan

M.J.

Poznauskis

Zurakowski

Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital—retrospective analysis of data in 12,494 patients

Radiology 2009; 250:674–681.

33.

Singh

Daftary

Iodinated contrast media and their adverse reactions

J Nucl Med Technol 2008; 36:69–74.

34.

Kapoor

W.N.

Current evaluation and management of syncope

Circulation 2002; 106:1606–1609.

35.

Hainsworth

Pathophysiology of syncope

Clin Auton Res 14 suppl 1 2004 18–24.

36.

Santini

Ammirati

Colivicchi

The effect of atropine in vasovagal syncope induced by head-up tilt testing

Eur Heart J 1999; 20:1745–1751.

37.

Povoa

Carneiro

A.H.

Adrenergic support in septic shock: a critical review

Hosp Pract (Minneap) 2010; 38:62–73.

38.

Thomsen

H.S.

Webb

J.A.W.

Contrast Media: Safety Issues and ESUR Guidelines 2nd ed 2009

Springer-Verlag

Berlin

39.

Bork

Siedlecki

Bosch

Asphyxiation by laryngeal edema in patients with hereditary angioedema

Mayo Clin Proc 2000; 75:349–354.

40.

Hagan

J.B.

Anaphylactoid and adverse reactions to radiocontrast agents

Immunol Allergy Clin North Am 2004; 24:507–519.

41.

Barach

E.M.

Nowak

R.M.

Lee

T.G.

Epinephrine for treatment of anaphylactic shock

JAMA 1984; 251:2118–2122.

42.

Smith

N.T.

Corbacio

A.N.

The use and misuse of pressor agents

Anesthesiology 1970; 33:58–101.

43.

Project Team of the Resuscitation Council

Emergency medical treatment of anaphylactic reactions

J Accid Emerg Med 1999; 16:243–247.

44.

Hughes

Fitzharris

Managing acute anaphylaxis: new guidelines emphasize importance of intramuscular adrenaline

BMJ 1999; 319:1–2.

45.

Simons

F.E.

Simons

K.J.

Outdated EpiPen and EpiPen Jr autoinjectors: past their prime?

J Allergy Clin Immunol 2000; 105:1025–1030.

46.

Brown

A.F.

Therapeutic controversies in the management of acute anaphylaxis

J Accid Emerg Med 1998; 15:89–95.

47.

Tole

J.W.

Lieberman

Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations

Immunol Allergy Clin North Am 2007; 27:309–326 viii

48.

ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. Version 7, 2010 (Web-based document). Available at: http://www.acr.org/SecondaryMainMenuCategories/quality_safety/contrast_manual/FullManual.aspx. Accessed May 15, 2011.

Safety Essentials: Acute Reactions to Iodinated Contrast Media

Abstract

Keywords

Get full access to this article

References